Pharmaceutical residues in untreated waste water samples according to Directive (EU) 2024/3019

The analysis determines the concentration of substances listed in Annex I to Directive (EU) 2024/3019 on urban wastewater treatment.

Substances that can be very easily treated:

  • Amisulprid (CAS: 71675-85-9)

  • Carbamazepine (CAS: 298-46-4)

  • Citalopram (CAS: 59729-33-8)

  • Clarithromycin (CAS: 81103-11-9)

  • Diclofenac (CAS: 15307-86-5)

  • Hydrochlorothiazide (CAS: 58-93-5)

  • Metoprolol (CAS: 37350-58-6)

  • Venlafaxine (CAS: 93413-69-5)

Substances that can be easily disposed of:

  • Benzotriazole (CAS: 95-14-7)

  • Candesartan (CAS: 139481-59-7)

  • Irbesartan (CAS: 138402-11-6)

  • 4-Methylbenzotriazole (CAS No 29878-31-7)

  • 5-methyl-benzotriazole (CAS No 136-85-6)

  • The sum of 4-Methylbenzotriazole & 5-methyl-benzotriazole can be reported if requested

This analysis is intended for untreated wastewater. We also offer an analysis with the same target analytes for treated wastewater to determine how effectively the substances are removed during the treatment process.

Suitable sample matrices
Untreated wastewater
Required sample quantity
100 mL in a dark glass bottle
Typical turnaround time
4 weeks after receiving the samples
Available quality systems
Accredited testing laboratory

Questions? We're happy to help.

Questions? We're happy to help.

Ringing phone
...and more than 700 other happy clients

Ask for an offer

Fill in the form, and we'll reply in one business day.

Answering the following questions helps us prepare an offer for you faster:

  • How many samples do you have and what is the sample material?
  • Do you have a recurring need for these tests? If yes, how often and for how many samples at a time?

Have questions or need help? Email us at or call our sales team.